The University of Chicago Header Logo

Connection

Harriet De Wit to Animals

Back to Details
This is a "connection" page, showing publications Harriet De Wit has written about Animals.
Harriet De Wit
Connection Strength
0.593
Animals
  1. The mesocorticolimbic system in stimulant use disorder. Mol Psychiatry. 2025 Nov; 30(11):5486-5499.
    View in: PubMed
    Score: 0.059
  2. Place conditioning in humans: opportunities for translational research. Psychopharmacology (Berl). 2023 Nov; 240(11):2221-2230.
    View in: PubMed
    Score: 0.049
  3. Acute Subjective and Behavioral Effects of Microdoses of Lysergic Acid Diethylamide in Healthy Human Volunteers. Biol Psychiatry. 2019 11 15; 86(10):792-800.
    View in: PubMed
    Score: 0.038
  4. Does human language limit translatability of clinical and preclinical addiction research? Neuropsychopharmacology. 2018 09; 43(10):1985-1988.
    View in: PubMed
    Score: 0.036
  5. Psychedelics and related drugs: therapeutic possibilities, mechanisms and regulation. Psychopharmacology (Berl). 2018 02; 235(2):373-375.
    View in: PubMed
    Score: 0.035
  6. Sweet taste liking is associated with subjective response to amphetamine in women but not men. Psychopharmacology (Berl). 2017 Nov; 234(21):3185-3194.
    View in: PubMed
    Score: 0.034
  7. Extinction of Conditioned Responses to Methamphetamine-Associated Stimuli in Healthy Humans. Psychopharmacology (Berl). 2016 07; 233(13):2489-502.
    View in: PubMed
    Score: 0.031
  8. Sex differences in impulsive action and impulsive choice. Addict Behav. 2014 Nov; 39(11):1573-1579.
    View in: PubMed
    Score: 0.026
  9. Using conditioned place preference to identify relapse prevention medications. Neurosci Biobehav Rev. 2013 Nov; 37(9 Pt A):2081-6.
    View in: PubMed
    Score: 0.025
  10. Do initial responses to drugs predict future use or abuse? Neurosci Biobehav Rev. 2012 Jul; 36(6):1565-76.
    View in: PubMed
    Score: 0.023
  11. Translational genetic approaches to substance use disorders: bridging the gap between mice and humans. Hum Genet. 2012 Jun; 131(6):931-9.
    View in: PubMed
    Score: 0.023
  12. Contextual conditioning enhances the psychostimulant and incentive properties of d-amphetamine in humans. Addict Biol. 2013 Nov; 18(6):985-92.
    View in: PubMed
    Score: 0.023
  13. Sex hormones: a new treatment for cocaine abuse? Neuropsychopharmacology. 2011 Oct; 36(11):2155-6.
    View in: PubMed
    Score: 0.023
  14. Genetics of caffeine consumption and responses to caffeine. Psychopharmacology (Berl). 2010 Aug; 211(3):245-57.
    View in: PubMed
    Score: 0.021
  15. Behavioral and biological indicators of impulsivity in the development of alcohol use, problems, and disorders. Alcohol Clin Exp Res. 2010 Aug; 34(8):1334-45.
    View in: PubMed
    Score: 0.020
  16. Challenges for translational psychopharmacology research--some basic principles. Psychopharmacology (Berl). 2008 Aug; 199(3):291-301.
    View in: PubMed
    Score: 0.018
  17. Association between the casein kinase 1 epsilon gene region and subjective response to D-amphetamine. Neuropsychopharmacology. 2006 May; 31(5):1056-63.
    View in: PubMed
    Score: 0.015
  18. The alcohol clamp: applications, challenges, and new directions--an RSA 2004 symposium summary. Alcohol Clin Exp Res. 2006 Jan; 30(1):155-64.
    View in: PubMed
    Score: 0.015
  19. GABA(B) receptor agonists for the treatment of drug addiction: a review of recent findings. Drug Alcohol Depend. 2002 Feb 01; 65(3):209-20.
    View in: PubMed
    Score: 0.012
  20. Using pharmacological manipulations to study the role of dopamine in human reward functioning: A review of studies in healthy adults. Neurosci Biobehav Rev. 2021 01; 120:123-158.
    View in: PubMed
    Score: 0.011
  21. Genomic basis of delayed reward discounting. Behav Processes. 2019 May; 162:157-161.
    View in: PubMed
    Score: 0.009
  22. Individual differences in acute effects of drugs in humans: their relevance to risk for abuse. NIDA Res Monogr. 1998 Mar; 169:176-87.
    View in: PubMed
    Score: 0.009
  23. Behavioral, biological, and chemical perspectives on targeting CRF(1) receptor antagonists to treat alcoholism. Drug Alcohol Depend. 2013 Mar 01; 128(3):175-86.
    View in: PubMed
    Score: 0.006
  24. Endocannabinoid signalling: has it got rhythm? Br J Pharmacol. 2010 Jun; 160(3):530-43.
    View in: PubMed
    Score: 0.005
  25. Differential effects of ethanol on serum GABAergic 3alpha,5alpha/3alpha,5beta neuroactive steroids in mice, rats, cynomolgus monkeys, and humans. Alcohol Clin Exp Res. 2010 Mar 01; 34(3):432-42.
    View in: PubMed
    Score: 0.005
  26. Nucleus accumbens lesions decrease sensitivity to rapid changes in the delay to reinforcement. Behav Brain Res. 2006 Oct 16; 173(2):217-28.
    View in: PubMed
    Score: 0.004
  27. Biological and behavioral markers of alcohol sensitivity. Alcohol Clin Exp Res. 2004 Feb; 28(2):247-56.
    View in: PubMed
    Score: 0.003
  28. Effects of morphine and naltrexone on impulsive decision making in rats. Psychopharmacology (Berl). 2004 Apr; 173(1-2):167-74.
    View in: PubMed
    Score: 0.003
  29. Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology. 2003 Sep; 28(9):1694-702.
    View in: PubMed
    Score: 0.003
  30. The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl). 2003 Jul; 168(1-2):3-20.
    View in: PubMed
    Score: 0.003
  31. Effects of d-amphetamine and alcohol on a measure of behavioral inhibition in rats. Behav Neurosci. 2000 Aug; 114(4):838-848.
    View in: PubMed
    Score: 0.003
  32. Determination of discount functions in rats with an adjusting-amount procedure. J Exp Anal Behav. 1997 May; 67(3):353-66.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.